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Purpose. To report the treatment outcome of photodynamic therapy with verteporfin (PDT) for exudative retinal detachment (RD)
associated with diffuse choroidal hemangioma in Sturge-Weber syndrome (SWS).Methods. An interventional case report of a 10-
year-old girl with SWS who developed an exudative RD (visual acuity hand motions) that was treated with PDT. She was treated
with a first session of multispot PDT. Posteriorly, a choroidotomy for drainage of subretinal fluid was created, combined with an
intravitreal injection of gas (SF
6
) and cryoapplication. Finally, a second session of PDTwas applied.Results. Subretinal fluid resolved
over a period of one year and visual acuity increased to 20/125. Conclusions. PDT is an effective therapeutic option for exudative
RD associated with diffuse choroidal hemangioma.
1. Introduction
Sturge-Weber syndrome (SWS) is a rare sporadic disorder
that occurs with a frequency of approximately 1/50 000
births [1, 2] and is characterized by cutaneous angioma
in a trigeminal distribution, leptomeningeal angioma, and
choroidal hemangioma [3]. Choroidal hemangioma is an
uncommon benign vascular tumor that can be either cir-
cumscribed or diffuse [4]. In SWS, choroidal hemangiomas
are usually diffuse, unilateral, and ipsilateral to the angioma-
tous malformation of the skin [5]. Patients with diffuse
choroidal hemangiomas are most likely to develop secondary
retinal detachment with shifting of the subretinal fluid [5,
6]. Diffuse choroidal hemangioma can lead to visual loss
due to refractive errors, foveal distortion, and exudative
retinal detachment [7]. Diffuse choroidal hemangiomas have
been treated with radiotherapy, proton beam, stereotactic
radiotherapy, plaque radiation therapy, and photodynamic
therapy (PDT) [5]. PDT is currently being advocated for
circumscribed choroidal hemangioma with good short-term
results [7]. To date, there have been only seven case reports of
successful PDT treatment for diffuse choroidal hemangiomas
[4, 5]. In this report we present our experience of treating a
choroidal hemangioma with PDT in the setting of SWS.
2. Case Report
A 10-year-old white girl with right-sided SWS was diagnosed
with right anisometropic amblyopia at age of 6 years and
responded to glasses with a stabilized visual acuity of 20/100
in the right eye. She underwent laser treatment of the
cutaneous nevus flammeus of the right side of the face with a
good cosmetic result.Therewas no history of glaucoma.Mag-
netic resonance imaging of the brain excluded intracranial
involvement. She presented with decreased vision in the right
eye to over a period of 6 months with a hyperopic shift from
4.00D to 6.00D. At presentation, her best-corrected visual
acuity (BCVA) was handmotions right eye and 20/20 left eye.
Intraocular pressures were normal without evidence of iris
neovascularization or abnormal conjunctival or scleral ves-
sels. Ophthalmoscopic evaluation revealed a tomato ketchup
red appearance of the right fundus comparedwith the left and
a serous retinal detachment (RD) of the right eye (Figure 1).
The entire inferior retina of the right eye was detached with
involvement of the macula. B-scan ultrasound and optical
coherence tomography (OCT) (Figure 2) confirmed the pres-
ence of a diffuse choroidal hemangioma with thickening
of the choroid and associated RD. Fluorescein angiography
showed diffuse early hyperfluorescence. The intense early
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Figure 1: Ophthalmoscopy revealed a tomato ketchup red appear-
ance of the fundus and an exudative retinal detachment.
Figure 2: OCT image confirmed the presence of a diffuse choroidal
hemangioma with thickening of the choroid and associated RD.
hyperfluorescence persisted through the laminar venous and
full venous phases and only faded in the late angiogram
phase. There was no fluorescein leakage from the retinal
circulation. The patient underwent PDT with parameters
typically used in treatment of choroidal neovascularization.
Two sessions of PDT where the tumor was thicker were
planned: the macula area and the area next to inferotem-
poral arcade. Verteporfin was infused at a concentration of
6mg/m2, and an 83-second treatment was conducted with
a 689 nm Zeiss laser that was delivered at 50 J/cm2 with an
intensity of 600mW/cm2. Firstly, four spots of 5300𝜇mwere
applied to the diffuse choroidal hemangioma in the macular
area. OCT was used to monitor treatment response. Two
weeks after treatment, there was a decrease in the thickness
of the choroidal tumor. However, because the amount of
subretinal fluid (mainly in lower quadrants) has not changed
(Figure 3), an inferotemporal choroidotomy for drainage of
subretinal fluid was created. This procedure was combined
with an intravitreal injection of gas (SF
6
) and cryoapplication
in the temporal quadrants. No complications were noted.
Forty days later, a second session of PDT treatment was
applied. Five spots of 5200𝜇m were applied out of the
inferotemporal arcade. The further PDT session resulted in
the total elimination of the subretinal fluid and the overlying
RD (Figure 4). One year after the treatment, the RD has not
recurred and BVCA improved to 20/125 right eye. No side
effects were noted.
3. Discussion
Histologic examination of eyes in patients with SWS has
suggested an incidence of choroidal hemangiomas of up
to 40% [8]. Exudative RD is one of the vision-threatening
complications. The management of RD in SWS is often
difficult. There are several ways to manage diffuse choroidal
hemangiomas. These include various modes of radiotherapy
and photodynamic therapy. Radiation and proton beam ther-
apy are effective modalities for diffuse hemangiomas but can
only be administered in specialized centers. Potential com-
plications include radiation retinopathy, optic neuropathy,
macula ischemia, and subretinal fibrosis [5]. Seven recently
published reports indicate that PDT with verteporfin can be
used as a therapeutic option for exudative RD associated
with diffuse choroidal haemangioma [4, 5]. Results show an
effective resolution of subretinal fluid. PDT is a safe and
effective modality that has several advantages over other
methods. This is an established method of treatment for age-
related macular degeneration, and most retina specialists are
familiar with its application. As published results of PDT
therapy in SWS were favourable and PDT is associated with
few systemic or ocular complications compared to the other
treatment options, PDTwas chosen as a first-line therapy [5].
In this case, after the first PDT session, the amount of
subretinal fluid (mainly in the lower quadrants) has not
changed. The resolution of subretinal fluid may take up to
6 months after PDT [5, 7]. However, because the amount of
retinal fluidwas extremely large in the inferior retina, and this
area had not yet been treated, the probability of subretinal
fluid resolution over time was very low. On the other side,
it was not possible to continue the treatment in inferior
retina because of poor visualization, consequent difficulty to
delimit the area where the tumor was thicker, and define
correctly the spots of PDT. In these conditions, PDT would
probably be ineffective. For these reasons, an inferotemporal
choroidotomy for drainage of subretinal fluid was created
to allow the second PDT session planned. Surgery in these
eyes is dangerous because of the risk of hemorrhage from the
dilated abnormal episcleral and choroidal vessels. To prevent
the risk of suprachoroidal hemorrhage, choroidotomy was
performed in the inferotemporal quadrant, as lower as
possible, at seven o’clock, where the tumor was very little
thick. Furthermore, the patient underwent sclerochoroidal
diathermy in the same area before external drainage of
subretinal fluid. Cryoapplication in the temporal quadrants
after the drainage also contributed to preventing the risk
of hemorrhage. The risk of retinal incarceration was low
because RD was very high. After the transchoroidal drainage
of subretinal fluid, the PDT was completed in the inferior
retina and allowed the total elimination of the subretinal fluid
and the overlying RD.
At this moment no recurring accumulation of subretinal
fluid associated with haemangioma in SWS has been
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Figure 3: Retinography (a) and OCT image (b) documented the amount of subretinal fluid in the lower retina.
Figure 4: OCT image confirmed the elimination of subretinal fluid
and the overlying RD after the second session of PDT.
reported; however, the follow-up period remains short.
Therefore the possibility of retreatment has to be taken into
account. We presented one case where PDT resulted in
resolution of exudative RD and helped improve visual acuity.
Diffuse choroidal hemangiomas associated with SWS are
uncommon but require aggressive treatment to prevent visual
loss from exudative RD and possibly subsequent sequelae
such as amblyopia. Our experience in this case confirms that
PDT with verteporfin is a therapeutic option for exudative
RD associated with diffuse choroidal hemangioma. However,
long-term follow-up will be necessary to confirm the efficacy
of the therapy and to document any further visual recovery.
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